Delivery Order SPE2DB24D1107-SPE2DB24FZEM0

Award Date 5/28/24
Potential Completion Date 5/29/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with a ceiling value of $2,864.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order, covers the supply of Felodipine ER 5 mg tablets in 100 count bottles. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,260.55 firm fixed-price delivery order is for the supply of 4,560,298 units of the prescription drug Felodipine ER 5 mg Tablet to support military healthcare programs. The award has a completion date of March 20, 2023 and was made without any set-aside designation, indicating full and open competition. Amerisourcebergen, a major...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 tablets of Felodipine extended-release 10 mg. The contract has a firm fixed price of $1,406.54 and a completion date of March 3, 2022. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,521.59 firm fixed price contract is for the delivery of 4,561,170,026 units of Felodipine Extended Release 5 mg tablets. The contract has a completion date of June 8, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,737.38, is for the delivery of 4,554,594 FELODIPINE ER 10 MG TABLET 500S. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc. This $999,999,999 IDC serves as the primary vehicle for Cencora to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.00 delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 5-20 MG 30S, a cardiovascular medication. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) that runs through January 2024, with no set-aside designation. Amerisourcebergen maintains a $999,999,999 IDC with the DLA...
This federal contract award, valued at $2,362.05, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,101.54 firm fixed-price delivery order contract is for the supply of AMLODIPINE-OLMESARTAN 10-40 MG 30S, a cardiovascular medication, to support military healthcare programs. The contract has an ultimate completion date of November 19, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,306.10 Firm Fixed Price Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The award covers 4565614762 - NIFEDIPINE ER 60 MG TABLET 300S, a cardiovascular medication, with a period of performance through August 29, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 IDC with the DLA, a key...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $1,745.76, is for the delivery of AMLODIPINE-VALSARTAN 10-320 mg 30-count tablets. This is a firm fixed price delivery order contract with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
  • SPE2DB24D1107
    Indefinite Delivery Contract
  • SPE2DB24D1107-SPE2DB24FZEM0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,731,229 tablets of the prescription medication Felodipine ER 2.5 mg. The $1,583.20 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense.

The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 8/27/24, 9:31 AM